493 related articles for article (PubMed ID: 11889043)
21. Regulation of class II expression in monocytic cells after HIV-1 infection.
Rakoff-Nahoum S; Chen H; Kraus T; George I; Oei E; Tyorkin M; Salik E; Beuria P; Sperber K
J Immunol; 2001 Aug; 167(4):2331-42. PubMed ID: 11490022
[TBL] [Abstract][Full Text] [Related]
22. The S box of major histocompatibility complex class II promoters is a key determinant for recruitment of the transcriptional co-activator CIITA.
Muhlethaler-Mottet A; Krawczyk M; Masternak K; Spilianakis C; Kretsovali A; Papamatheakis J; Reith W
J Biol Chem; 2004 Sep; 279(39):40529-35. PubMed ID: 15271997
[TBL] [Abstract][Full Text] [Related]
23. HDAC2 deacetylates class II transactivator and suppresses its activity in macrophages and smooth muscle cells.
Kong X; Fang M; Li P; Fang F; Xu Y
J Mol Cell Cardiol; 2009 Mar; 46(3):292-9. PubMed ID: 19041327
[TBL] [Abstract][Full Text] [Related]
24. Role of PU.1 in MHC class II expression through transcriptional regulation of class II transactivator pI in dendritic cells.
Kitamura N; Yokoyama H; Yashiro T; Nakano N; Nishiyama M; Kanada S; Fukai T; Hara M; Ikeda S; Ogawa H; Okumura K; Nishiyama C
J Allergy Clin Immunol; 2012 Mar; 129(3):814-824.e6. PubMed ID: 22112519
[TBL] [Abstract][Full Text] [Related]
25. The zinc finger proteins ZXDA and ZXDC form a complex that binds CIITA and regulates MHC II gene transcription.
Al-Kandari W; Koneni R; Navalgund V; Aleksandrova A; Jambunathan S; Fontes JD
J Mol Biol; 2007 Jun; 369(5):1175-87. PubMed ID: 17493635
[TBL] [Abstract][Full Text] [Related]
26. MHC class II transactivator represses human IL-4 gene transcription by interruption of promoter binding with CBP/p300, STAT6 and NFAT1 via histone hypoacetylation.
Zhou X; Jiang Y; Lu L; Ding Q; Jiao Z; Zhou Y; Xin L; Chou KY
Immunology; 2007 Dec; 122(4):476-85. PubMed ID: 17645498
[TBL] [Abstract][Full Text] [Related]
27. CREB and phospho-CREB interact with RFX5 and CIITA to regulate MHC class II genes.
Lochamy J; Rogers EM; Boss JM
Mol Immunol; 2007 Feb; 44(5):837-47. PubMed ID: 16730065
[TBL] [Abstract][Full Text] [Related]
28. Novel mutations within the RFX-B gene and partial rescue of MHC and related genes through exogenous class II transactivator in RFX-B-deficient cells.
Nagarajan UM; Peijnenburg A; Gobin SJ; Boss JM; van den elsen PJ
J Immunol; 2000 Apr; 164(7):3666-74. PubMed ID: 10725724
[TBL] [Abstract][Full Text] [Related]
29. Different levels of control prevent interferon-gamma-inducible HLA-class II expression in human neuroblastoma cells.
Croce M; De Ambrosis A; Corrias MV; Pistoia V; Occhino M; Meazza R; Giron-Michel J; Azzarone B; Accolla RS; Ferrini S
Oncogene; 2003 Oct; 22(49):7848-57. PubMed ID: 14586411
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the transcriptional regulation of classical and non-classical MHC class II genes.
Hake SB; Tobin HM; Steimle V; Denzin LK
Eur J Immunol; 2003 Sep; 33(9):2361-71. PubMed ID: 12938212
[TBL] [Abstract][Full Text] [Related]
31. Degradation, Promoter Recruitment and Transactivation Mediated by the Extreme N-Terminus of MHC Class II Transactivator CIITA Isoform III.
Beaulieu YB; Leon Machado JA; Ethier S; Gaudreau L; Steimle V
PLoS One; 2016; 11(2):e0148753. PubMed ID: 26871568
[TBL] [Abstract][Full Text] [Related]
32. Histone deacetylation, but not hypermethylation, modifies class II transactivator and MHC class II gene expression in squamous cell carcinomas.
Kanaseki T; Ikeda H; Takamura Y; Toyota M; Hirohashi Y; Tokino T; Himi T; Sato N
J Immunol; 2003 May; 170(10):4980-5. PubMed ID: 12734341
[TBL] [Abstract][Full Text] [Related]
33. Cis-element dependence and occupancy of the human invariant chain promoter in CIITA-dependent and -independent transcription.
Tai AK; Zhou G; Chau K; Ono SJ
Mol Immunol; 1999 May; 36(7):447-60. PubMed ID: 10449097
[TBL] [Abstract][Full Text] [Related]
34. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients.
Masternak K; Barras E; Zufferey M; Conrad B; Corthals G; Aebersold R; Sanchez JC; Hochstrasser DF; Mach B; Reith W
Nat Genet; 1998 Nov; 20(3):273-7. PubMed ID: 9806546
[TBL] [Abstract][Full Text] [Related]
35. New functions of the major histocompatibility complex class II-specific transcription factor RFXANK revealed by a high-resolution mutagenesis study.
Krawczyk M; Masternak K; Zufferey M; Barras E; Reith W
Mol Cell Biol; 2005 Oct; 25(19):8607-18. PubMed ID: 16166641
[TBL] [Abstract][Full Text] [Related]
36. Two B cell factors bind the HLA-DRA X box region and recognize different subsets of HLA class II promoters.
Hasegawa SL; Boss JM
Nucleic Acids Res; 1991 Nov; 19(22):6269-76. PubMed ID: 1956787
[TBL] [Abstract][Full Text] [Related]
37. The class II transactivator requires brahma-related gene 1 to activate transcription of major histocompatibility complex class II genes.
Mudhasani R; Fontes JD
Mol Cell Biol; 2002 Jul; 22(14):5019-26. PubMed ID: 12077331
[TBL] [Abstract][Full Text] [Related]
38. Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5.
Scholl T; Mahanta SK; Strominger JL
Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6330-4. PubMed ID: 9177217
[TBL] [Abstract][Full Text] [Related]
39. Dysregulated recruitment of the histone methyltransferase EZH2 to the class II transactivator (CIITA) promoter IV in breast cancer cells.
Truax AD; Thakkar M; Greer SF
PLoS One; 2012; 7(4):e36013. PubMed ID: 22563434
[TBL] [Abstract][Full Text] [Related]
40. Regulation of major histocompatibility (MHC) class II human leukocyte antigen-DR alpha gene expression in thyrocytes by single strand binding protein-1, a transcription factor that also regulates thyrotropin receptor and MHC class I gene expression.
Balducci-Silano PL; Suzuki K; Ohta M; Saito J; Ohmori M; Montani V; Napolitano G; Shong M; Taniguchi SI; Pietrarelli M; Lavaroni S; Mori A; Singer DS; Kohn LD
Endocrinology; 1998 May; 139(5):2300-13. PubMed ID: 9564838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
